The use of extracorporeal membrane oxygenation for respiratory failure is high risk and resource intensive. In England, five centres provide this service and patients who are referred have four possible outcomes: declined transfer due to perceived futility; accepted in principle but remain at the referring centre with ongoing surveillance; retrieved using conventional ventilation; or retrieved on extracorporeal support. The decision-making process leading to these outcomes has not previously been examined. We evaluated referrals to one centre and identified factors associated with each decision outcome. Five hundred and sixty-four patients were analysed from January 2012 to October 2015. One hundred and fifty-seven patients were declined; multivariate analysis demonstrated associated factors to be: age (odds ratio (95% confidence interval) 1.05 (1.04-1.07)); immunocompromise (4.95 (2
Introduction
Acute respiratory distress syndrome (ARDS) is a diffuse, inflammatory condition of diverse aetiology affecting the lungs. In severe cases, in which hypoxaemia or hypercarbia prove refractory to conventional mechanical ventilation, transfer to a specialist centre offering veno-venous extracorporeal membrane oxygenation (VV-ECMO) improves the likelihood of disability-free survival [1] . In England, provision of VV-ECMO is regionalised to a network of five commissioned severe respiratory failure centres (SRFC).
Patient entry into the SRFC system has implications at both an individual and societal level. Transfer confers inherent risk and distances patients from friends and family; the initiation of VV-ECMO carries specific risks, such as cardiovascular injury [2] , haemorrhage [3] and venous thrombus formation [4, 5] , and comes at substantial cost to the health system [6] . Decision making at the time of referral must, therefore, seek to select patients for whom SRFC involvement is potentially beneficial. Selected patients should then be allocated a level of SRFC support sufficient to meet their physiological needs, without exposing the individual to unnecessary risk or the health system to unnecessary strain. Evaluation of the decision-making process at the point of referral to the SRFC system is, therefore, important and desirable.
For patients referred to our regional SRFC, there are four potential referral outcomes (Fig. 1) . If, following discussion with the referring centre, the underlying disease process is felt to lack potential for reversibility, or the patient is deemed to have insufficient physiological reserve to survive the critical illness, then SRFC input is considered inappropriate and the patient is declined. For accepted patients, an assessment is then made of illness severity and whether respiratory support requirements can currently be met locally. If so, the patient remains at the referring centre with remote, telephone support from the SRFC; any subsequent deterioration would prompt re-evaluation. For accepted patients, whose support requirements exceed local capabilities, a VV-ECMO-capable, consultant-led team is dispatched. The patient is reviewed at the referring centre and either established on VV-ECMO before transfer, or retrieved using conventional ventilation. The retrieval process has been described in detail previously [7] .
In this paper, we evaluate this decision-making process. First, we sought to understand the factors associated with a perceived lack of reversibility or reserve and hence a decision to decline SRFC input. Second, we identified factors associated with the decision to manage the accepted patient at the referring centre or to retrieve, and the subsequent decision to retrieve on VV-ECMO or on conventional ventilation. Third, we examined 6-month survival of each decision outcome group. Finally, we applied the Respiratory ECMO Survival Prediction (RESP) score [8] to patients within our cohort and considered the utility of this previously validated predictive score to support decision making when applied at the time of referral.
Methods
The study had institutional approval. Need for individual informed consent was waived for this retrospective analysis of data collected prospectively for routine care with no breach of privacy or anonymity. The study qualified as a service evaluation as defined by the UK NHS Health Research Authority (NHS HRA) and therefore did not require review by a research ethics committee.
Guy's and St. Thomas' NHS Foundation Trust (London, England) is a 1150-bed, university teaching hospital with a semi-closed, mixed medical and surgical ICU (approximately 70% medical and 30% surgical admissions). It is one of five commissioned SRFCs in England. The service manages 60-100 patients who require VV-ECMO annually. Clinical care of these patients is protocolised and directed by eight critical care physicians with an interest in severe respiratory failure and VV-ECMO using a standardised pathway and multidisciplinary team approach.
Patients referred to the SRFC between January 2012 and October 2015 formed the study cohort. Patients initially referred to our centre who either died during the assessment process, or whose care was passed to another SRFC due to capacity issues, were omitted from the analysis.
Our service maintains a database of all referrals to the SRFC. This includes baseline characteristics, physiological and comorbid details. All referral data are entered at the time of first telephone contact before decision making regarding management, retrieval to the SRFC or initiation of VV-ECMO. Data points within the SRFC database were based upon the Extracorporeal Life Support Organization registry which has previously been used to develop predictive scoring systems [8] . Figure 1 Severe respiratory failure referral decision-making process and subsequent patient management groups. SRFC, severe respiratory failure centre; ECMO, extracorporeal membrane oxygenation.
Two investigators (KR and SG) extracted data from the SRFC database. Reviews of free text entries were conducted to ensure the maximum number of parameters was captured. Six-month survival was determined from the NHS Digital Summary Care Records database.
Factors reported to be associated with survival outcome in previous VV ECMO-related outcome models, namely RESP [8] , PRESERVE [9] and ECMOnet [10] , were included in this analysis where possible.
Patients were allocated to one of the diagnostic categories described in the RESP score: bacterial pneumonia; viral pneumonia; aspiration pneumonitis; asthma; trauma; other acute respiratory diagnosis; or non-respiratory diagnosis. This was based on the information available at the time of referral rather than definitive discharge diagnosis. In keeping with the RESP score [8] , cardiac failure was defined as acute or chronic, and renal failure was defined as a serum creatinine greater than 133 mmol.l À1 or by the use of renal replacement therapy. Patients were considered to have an acute associated infection if the referral record indicated any form of extrapulmonary infective process. Immunocompromise referred to malignancy (solid or haematological), human immunodeficiency virus, solid organ transplant or cirrhosis apparent at the time of referral. Driving pressure was defined as the difference between peak inspiratory pressure and positive endexpiratory pressure (PEEP). For the purposes of this paper, reversibility relates to the acute process underpinning referral to the SRFC and is defined by the presence of a condition that has the potential to resolve either spontaneously or in response to treatment. Physiological reserve is defined as the individual's capacity to survive the stresses of critical illness and is determined largely by comorbidities. Severity describes the degree of physiological derangement and resultant need for organ support.
It was postulated that, from a pragmatic perspective, the retrieval distance might impact on the decision to retrieve and to initiate mobile VV-ECMO. The road distances between referring hospitals and our centre were, therefore, included, as calculated by an online map application [11] .
The RESP score is a prognostic model suggested as offering a means of helping "clinicians select appropriate candidates for ECMO, informing family members of likely prognosis and facilitating riskadjusted comparison of centre-specific outcomes" [8] . It was generated using the Extracorporeal Life Support Organization voluntary registry data of 2355 patient episodes from 280 international centres and is, therefore, the most generalisable prognostic model currently available. This model identifies 12 pre-VV ECMO variables, in patients already cannulated for VV-ECMO, which were independently associated with hospital survival, and categorises patients into five risk categories. We applied the RESP score to all patients referred to our centre using the data available at the time of referral. Predicted and observed survival were then compared across groups.
Statistical analyses were performed using R (https:// www.r-project.org/). Univariate analyses were performed with Wilcoxon signed-rank test for continuous variables and chi-squared test for categorical variables. Those factors with a p < 0.10 in the univariate analysis were entered into a forward stepwise multivariate logistic regression model to examine for independent association. A p ≤ 0.05 was taken to be statistically significant.
Results
Database interrogation identified 578 patients referred to the SRFC over the study period. Five patients died during the assessment process and the care of nine patients was transferred to other centres due to capacity issues; these 14 patients were not analysed. Among the remaining 564 patients, 157 were declined ongoing SRFC management, 115 were managed in the referring centre with SRFC advice, and 292 were retrieved (219 on VV-ECMO and 73 with conventional ventilation) ( Fig. 1) .
Six-month outcome data were available for 145 (92%) of declined patients, 97 (84%) of patients managed in the referring centre and 292 (100%) of patients retrieved to our SRFC.
In the univariate analysis comparing patients accepted onto the SRFC pathway with those declined on the basis of lack of perceived reversibility or reserve, the primary differences were age, precipitating pathology and the presence of comorbidities (Table 1) . Multivariate analysis found increasing age (OR 1.05 (95% CI 1.04-1.07)), the presence of immunocompromise (OR 4.95 (95%CI 2.58-9.67)), increasing arterial lactate (OR 1.11 (95%CI 1.01-1.22)), duration of mechanical ventilation (OR 1.08 (95%CI 1.04-1.14)) and the presence of cardiac failure (OR 3.22 (95%CI 1.04-10.51)) to be independent predictors of being declined SRFC input.
For those patients in whom outcome data were available, 72.8% of patients accepted onto the SRFC pathway survived 6 months, in comparison with 16.6% among those declined (p < 0.001).
The differences between the group retrieved to the SRFC for further management and the group managed in the referring centre with remote advice, relate primarily to respiratory parameters (Table 2) . No statistically significant difference in baseline characteristics or comorbid factors was identified. In multivariate analysis, plateau pressure (OR 1.05 (95%CI 1.01-1.10)), PaCO 2 (OR 1.13 (95%CI 1.03-1.25)), ratio of arterial oxygen partial pressure to fractional inspired oxygen (PF ratio) (OR 0.89 (95%CI 0.85-0.93)), and the presence of an acute non-pulmonary infection (OR 0.31 (95%CI 0.15-0.61)) were found to be significantly and independently associated with the decision to undertake retrieval. There was no statistically significant difference in 6-month survival in patients retrieved to SRFC or managed in the referral centre (73.3% vs. 71.1%, respectively; p = 0.680). When the RESP score was applied to those patients managed remotely by the SRFC at the referring hospital, the score underestimated survival in those patients in the higher risk groups (Fig. 2) .
There were three significant differences between those patients retrieved using mechanical ventilation and those who required VV-ECMO for ongoing management of respiratory failure (eSupplement Table 7 ). Patients placed on VV-ECMO had a lower pH at the time of referral, lower PF ratio and a higher median creatinine. Only pH remained significant in the multivariate model (OR 0.02 (95%CI 0.002-0.017)). There was no difference in the retrieval distance between the two groups. There was no difference in 6-month survival in patients retrieved on VV-ECMO compared with conventional ventilation (72.1% vs. 76.7%, respectively; p = 0.445).
When the RESP score was applied to patients retrieved to the SRFC, either on VV-ECMO or conventional ventilation, the survival estimated by RESP for those in high-risk groups was underestimated (Fig. 2) . 
Discussion
In this paper, we have analysed decisions surrounding referrals to a regional SRFC. It is our perception that the decisions to accept patients are determined by potential reversibility and recovery, and subsequent decisions regarding need for retrieval and VV-ECMO are governed by illness severity. This perception was substantially supported. Availability of critical care beds is limited, and such finite resources must be allocated to those deemed most likely to benefit. This is particularly true for specialist services such as VV-ECMO. Resource limitation aside, VV-ECMO is highly invasive and requires transfer to a regional centre. From a bio-ethical perspective, this pathway is inappropriate for those expected to die despite intervention.
Within the English network, referral triggers and acceptance decisions are guided by criteria from the CESAR trial [1] . Recently, predictive models have been developed which seek to further support decision making, namely the RESP [8] , PRESERVE [9] and ECMOnet [10] models. These have been proposed as an adjunct to patient selection, yet attempts at external validation demonstrated poor predictive capacity [12, 13] .
Guy's and St Thomas' NHS Foundation Trust does not utilise a predictive scoring system. Instead a collaborative assessment is undertaken with referring colleagues. Expert assessment is not a novel approach; similar decision-making models have been described for patients referred to critical care [14] [15] [16] [17] [18] with age, premorbid dependency, underlying diagnosis, illness severity, and bed availability identified as factors influencing admission decisions.
Within our cohort, the group declined SRFC input was older, had a longer duration of ventilation, higher incidence of immunocompromise and higher arterial lactate. The first three factors, which were non-modifiable at time of referral, are associated with increased mortality in intensive care patients [19, 20] and recipients of VV-ECMO [8] [9] [10] . The finding that these factors are more common in the declined group is consistent with our perception that acceptance is based on degree of reversibility and reserve.
The small, but statistically significant, difference in lactate could challenge the reversibility and reserve hypothesis. Typically, lactate is interpreted as a marker of acute haemodynamic failure [21] . Therefore, elevated lactate suggests that severity of acute illness contributes to the decision to decline SRFC input. However, the simplicity of lactate as a marker of the acute haemodynamic state is debated [22] . Lactate sources in critical illness are many, and rates of lactate generation and clearance are influenced by several chronic disease factors [23] . Higher lactate in the declined group may reflect comorbidities and limited physiological reserve.
The decision to retrieve or manage patients in the referring centre is determined by the level of respiratory support required. Plateau pressure and PaCO 2 were greater and PF ratio lower in those retrieved. Interestingly, extrapulmonary infections were more common in the group managed at the referring centre. This may reflect a perception that ARDS of extrapulmonary aetiology is more responsive to recruitment manoeuvres, PEEP titration and mechanical ventilation of the lungs in the prone position [24, 25] . Although this concept is not universally accepted [26] , it may contribute to retrieval decisions.
The two groups retrieved were physiologically different, with the ECMO group exhibiting worse gas exchange and renal function. However, on multivariate analysis, the only factor predicting mobile VV-ECMO initiation vs. mechanical ventilation retrieval was pH. Virtually all transfers were undertaken by road, requiring critically ill patients to be managed in an ambulance for several hours. However, transfer distance did not appear to influence the decision to establish on mobile VV-ECMO for retrieval, suggesting a focus on clinical need, rather than logistical expediency.
For patients referred to, but declined by, the SRFC, 6-month survival was 16.6%. This is worthy of discussion. Declined survivors demonstrated both a reversible acute pathology and sufficient reserve to survive critical illness. This suggests that the assessment, despite being based upon a comprehensive, structured and collaborative process, fails to identify reversibility and reserve in a small, but significant, proportion. In previous studies examining general critical care admission decisions [14] [15] [16] [17] [18] , 28-day survival of those declined due to perceived futility ranged from 10% to 35%, suggesting some inability of clinicians to accurately identify futility.
In those accepted onto the SRFC pathway, but managed in the referring centre, 71.1% survived 6 months. This is not significantly different from the 73.3% survival of those retrieved to the SRFC and suggests that, with appropriate assessment, selection and remote advice, many patients referred to a regional centre with severe respiratory failure can be safely and effectively managed without retrieval. However, in this group, defined by less profound respiratory failure, it is of concern that mortality is comparable to those retrieved. It is not clear from our data why these nonretrieved patients die. Some may develop a second pathology (e.g. visceral ischaemia or nosocomial infection) distinct from the initial respiratory condition, for which SRFC input is deemed ineffective. It is not clear whether a policy of retrieving all accepted patients would improve survival in this lower acuity group, or whether this would be viable from a resource perspective. Once again, examination of data relating to general critical care admission [14] [15] [16] [17] [18] reveals a similar pattern; 28-day survival of patients declined on the basis of being 'too well' ranged from 86% to 92%. The ability of clinicians to identify those who can be safely and successfully managed without admission to critical care is imperfect.
Six-month survival was 73.3% of those retrieved to the SRFC. This survival exceeds that reported by an earlier series of undifferentiated severe respiratory failure managed by regional centres which ranged from 61.5% to 64% [1, 9, 12] . There are several possible explanations for this finding. Firstly, the conventional management of severe respiratory failure has evolved over the last 10 years. Practices which have been demonstrated to reduce mortality such as protective ventilation [27] , prone positioning [28] and use of neuromuscular blocking agents [29] have been widely adopted. Secondly, technology surrounding VV-ECMO has advanced and clinicians have gained greater understanding of its use. Finally, in England, SRFC and VV-ECMO capacity has increased significantly since CESAR [1] ; it is possible that, although the criteria for VV-ECMO established by CESAR remain the cornerstone of decision making, the threshold to refer and accept patients with severe respiratory failure may have changed. Managing more patients on a protocolised pathway may also have impacted positively on outcome. Of note, there is no difference in survival between patients retrieved using conventional mechanical ventilation and using VV-ECMO. This is in accordance with previous studies [1, 30] but differs from others [31] . There were significant physiological differences between these two groups in our analysis. However, our methodology does not allow us to draw any conclusion about the efficacy of VV-ECMO as an intervention for transfer.
In all groups, the RESP model [8] underestimated survival of those patients with lower RESP scores (indicative of a greater severity of illness). The utility of scoring systems in the prediction of survival has been questioned previously [32] . This is particularly true of systems, like RESP, which observe physiology at a single time point [33, 34] . Additionally, application of scoring systems generated from large international datasets to specific centres or regions, has been associated with poor predictive capacity [35, 36] which is only slightly improved by recalibration [37] . The RESP score was generated from a cohort already established on VV-ECMO and therefore the applicability of this model to patients at the time of referral to an SRFC is questionable.
Our paper has strengths and limitations. Care of those patients accepted for SRFC input is coordinated by a small group of critical care physicians and therefore is largely standardised. The dataset is representative of the information available at time of referral (and hence decision making). This differs from other retrospective analyses of VV-ECMO cohorts in which some factors such as definitive diagnosis and neurological status are added to the dataset later. Limitations include the single centre nature of this study, the retrospective collection of data from databases not specifically established to clarify the mechanisms described in this manuscript and the potential for misclassification of referral outcomes by the clinician coders. Some data were missing (eSupplement Table 2 ); although multivariate regression was conducted via a complete case analysis technique, these missing data inevitably impacted statistical power. Finally, there are limitations relating the heterogeneity of referring centres in terms of size, resources and capability to deliver more advanced respiratory support. These considerations no doubt will affect the need for transfer and may influence the external validity of this study. This is, to our knowledge, the first published analysis of the factors and outcomes relating to referral decisions in a regional SRFC. The outcomes support our approach of using reversibility, reserve and severity of acute illness to allocate and stratify regional resources. Survival in those declined on the basis of perceived futility and the mortality in those accepted, but managed in the referring centre on the basis of low severity of illness, are both cause for reflection. These findings could suggest that our approach is imperfect, although there are likely to be a multitude of outcome-determining factors not captured in our analysis. A more robust, objective system is desirable and the use of a predictive model appealing. However, one predictive model, when applied to our cohort at the time of referral, underestimated survival in patients with higher severity of illness. Respiratory ECMO Survival Prediction scores must, therefore, be used with great caution when making decisions about resource allocation in severe respiratory failure. Table S2 . Availability of data by factors and decision group. Table S3 . Multivariate regression of factors associated with patients declined SRFC input on basis of perceived lack of reverse or reversibility. Table S4 . Multivariate regression of factors associated with patients accepted by SRFC being retrieved. Table S5 . Univariate analysis of comparing patients retrieved on ECMO and those retrieved on mechanical ventilation alone. Table S6 . Multivariate regression of factors associated with retrieved patients being transferred on mobile VV-ECMO. Table S7 . Comparison of baseline characteristics of the RESP cohort with those patients who received VV-ECMO at our institution.
